Thus, our findings of the increased levels of IL‐7, IL‐8, and TNF‐α (Fig. 1) in patients with prostate cancer are consistent with characteristic features of prostate cancer reported previously. This evidence concerns the gene CXCL8 and prostate carcinoma.